未用药的杂合家族性地中海热患者的转录组分析揭示驱动Pyrin表达升高的I型干扰素特征
研究比较10例未治疗无症状期家族性地中海热(FMF)患者与5例健康MEFV突变携带者的外周血单个核细胞转录组,发现147个差异表达基因,富集于I型干扰素信号和炎症小体通路,ISG15、IFIT2、STAT1及Pyrin编码基因MEFV上调;功能实验显示I型干扰素刺激可增加Pyrin蛋白水平。作者提出I型干扰素信号作为「二次打击」放大杂合子Pyrin表达,解释单突变携带者出现疾病表型的现象。
要点
- FMF患者与健康携带者PBMC转录组存在147个差异表达基因,富集于I型干扰素信号和炎症小体通路。
- I型干扰素刺激可增加PBMC和分离单核细胞中Pyrin蛋白水平,提示干扰素反应与炎症小体信号存在交互。
- 作者认为I型干扰素信号作为「二次打击」放大杂合子Pyrin表达,使单MEFV突变者出现疾病表现。
核心结论
- 作者认为I型干扰素信号作为关键「二次打击」放大杂合子个体Pyrin表达,使单MEFV突变者出现疾病表现。
- 该研究为FMF等疾病中携带者表现疾病表型的长期争议提供解释,并为精准诊断和治疗干预提供新思路。
研究设计与样本
- 研究纳入10例FMF患者(表型携带者/纯合子)和5例健康MEFV突变携带者,于无症状、未治疗期分离外周血单个核细胞(PBMC)。
- 转录组分析采用去珠蛋白mRNA、链特异性Qiaseq文库,在Illumina NextSeq 500/550双端测序,差异表达分析使用TMM标准化负二项模型(|log₂FC|>1,校正P<.01),并行Reactome通路富集。
- 免疫印迹使用健康个体经干扰素(IFN)-α刺激的单核细胞/PBMC裂解变性后,以针对IRF-3、ISG15、Pyrin、STAT1、AIM2、caspase-5、β-actin的抗体检测;CXCL10采用Luminex定量。
主要发现
- PBMC转录组分析显示147个差异表达基因。
- 通路分析显示I型干扰素信号和炎症小体相关通路富集,I型干扰素刺激基因ISG15、IFIT2、STAT1及炎症小体感受器Pyrin(由FMF突变基因MEFV编码)明显上调。
- 功能实验显示I型干扰素刺激增加PBMC和分离单核细胞中Pyrin蛋白水平,揭示干扰素反应与炎症小体信号间的交互。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Familial Mediterranean fever (FMF) is traditionally viewed as an autosomal recessive autoinflammatory disorder. However, a significant subset of patients harbouring a single pathogenic MEFV mutation exhibit a clinical phenotype indistinguishable from that of homozygous patients. We aimed to compare the transcriptomic profiles of patients carrying a single pathogenic mutation who exhibit the classical FMF phenotype with those of healthy carriers (with 1 pathogenic mutation), as well as with homozygous or compound heterozygous patients (with 2 pathogenic mutations), to identify differential molecular signatures and potential diagnostic pathways. METHODS: Peripheral blood mononuclear cells (PBMCs) from 10 patients with FMF (phenotypic carriers/homozygotes) and 5 healthy MEFV mutation carriers were isolated during asymptomatic, treatment-naïve phases. Transcriptome profiling employed globin mRNA-depleted, strand-specific Qiaseq libraries sequenced on Illumina NextSeq 500/550 (paired-end). Differential expression analysis applied TMM (trimmed mean of M values) based-normalised negative binomial models (|log₂FC| > 1, adjusted *P* < .01), with Reactome pathway enrichment. For immunoblotting, interferon (IFN)-α-stimulated monocytes/PBMCs of healthy individuals were lysed, denatured, and probed with antibodies targeting key proteins (IRF-3, IFN-stimulated gene 15 [ISG15], Pyrin, STAT1, AIM2, caspase-5, β-actin). CXCL10 levels were quantified using Luminex. RESULTS: PBMC profiling revealed 147 differentially expressed genes. Pathway analyses highlighted enrichment in type I IFN signalling and inflammasome-related pathways, with marked upregulation of type I ISGs: ISG15, IFIT2, STAT1, and the inflammasome sensor Pyrin encoded by the MEFV gene, mutated in FMF. Moreover, functional assays demonstrated that type I IFN stimulation increases Pyrin protein levels in PBMCs and isolated monocytes, revealing cross-talk between IFN responses and inflammasome signalling. CONCLUSIONS: These findings suggest that type I IFN signalling acts as a critical 'second hit', amplifying Pyrin expression in heterozygous individuals and enabling disease manifestation despite a single MEFV mutation. This study offers an explanation for the much-debated issue of the carriers expressing disease phenotypes in diseases such as FMF and presents novel insights for precision diagnosis and therapeutic intervention.
引用
- Sag E, Imren G, Walle LV, et al. Transcriptome analysis of unmedicated heterozygous familial Mediterranean fever patients reveals a type I interferon signature driving increasing Pyrin expression. Ann Rheum Dis. 2025. PMID: 40883219. doi:10.1016/j.ard.2025.08.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。